Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Gastroesophageal Reflux 2Barrett Esophagus 2Zollinger-Ellison Syndrome 1Adenocarcinoma Of Esophagus 1

Interventions

Endoscopy 15Endoscopy, Digestive System 13Biopsy 11Endoscopic Mucosal Resection 8Specimen Handling 7Radiofrequency Ablation 7Esomeprazole 7Gastroscopy 6Proflavine 4Omeprazole 4Aspirin 4Narrow Band Imaging 3Diagnostic Imaging 3Breath Tests 3YF 476 2Proton Pump Inhibitors 2Photochemotherapy 2Microscopy, Confocal 2Metformin 2Lansoprazole 2Itraconazole 2Endoscopes 2Dexlansoprazole 2Cryotherapy 2Cryosurgery 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2rofecoxib 1polyphenon E 1plecanatide 1omeprazole, sodium bicarbonate drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Barrett Esophagus × YF 476 × Clear all
NCT01298999 2021-11-23

Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus

Columbia University

Phase 2 Completed
27 enrolled 16 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Gastroesophageal Reflux

NCT02597712 2021-04-12

YF476 in Barrett's Esophagus

Trio Medicines Ltd.

Phase 2 Completed
27 enrolled 15 charts
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡